Filing Flows › Elanco Animal Health (ELAN) › Q3 2026
Elanco Animal Health (ELAN) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 6, 2026
Elanco Animal Health (ELAN) reported revenue of $1.3B for the third quarter 2026 (Q3 2026), +11% from a year earlier and -8% from the quarter before. Operating margin was 1.9%, net earnings $18.0M (1.4% of revenue).
Elanco Animal Health, Q3 2026: revenue $1.3B (+11% year over year), operating margin 1.9%, net earnings $18.0M, operating cash flow $216M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3B | -8% | +11% |
| Gross profit | $720M | -10% | +19% |
| Operating profit | $24.0M | -57% | — |
| Net earnings | $18.0M | -67% | — |
| Operating cash flow | $216M | -22% | -1% |
| Free cash flow | $156M | -36% | +23% |
What changed
Revenue was $1.3B in Q3 2026, up 11% year over year and down 8% from the previous quarter. Pet Health was the largest line at 48% of revenue. Pet Health added $0.07B year over year (up 14%), 59% of the total change. Poultry declined 7%.
Gross margin was 56.9%, up 3.5 points from Q3 2025. Operating profit was $0.02B, a 1.9% margin (up 6.3 points year over year). Operating expenses grew 6% against revenue growth of 11%. The fastest-growing cost line was SG&A (+12%). Net earnings were $0.02B. The effective tax rate was 25.0%.
Operating cash flow was $0.22B (down 1% year over year), 1200% of net earnings. Non-cash charges added back $0.18B of depreciation and amortization and $0.02B of share-based compensation. Capital expenditures of $0.06B left free cash flow of $0.16B.
Questions
What was Elanco Animal Health's revenue in the third quarter 2026?
Elanco Animal Health (ELAN) reported revenue of $1.3B for the third quarter 2026 (Q3 2026), +11% from a year earlier and -8% from the quarter before.
Was Elanco Animal Health profitable in the third quarter 2026?
Operating profit was $24.0M (1.9% of revenue) and net earnings $18.0M.